Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
CohBar, Inc. CWBR
$1.58
+$0.01 (0.32%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
4709227.00000000
-
week52high
7.50
-
week52low
1.43
-
Revenue
0
-
P/E TTM
0
-
Beta
1.89619300
-
EPS
-4.01000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| WBB Securities | Buy | Speculative Buy | 11 авг 2021 г. |
| Maxim Group | Buy | 23 апр 2021 г. | |
| Aegis Capital | Buy | 15 мар 2021 г. | |
| Chardan Capital | Buy | 17 дек 2020 г. | |
| WBB Securities | Speculative Buy | 15 окт 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sarret Joseph J. | A | 151017 | 131017 | 01 авг 2022 г. |
| Biunno Jeffrey Francis | A | 57355 | 26203 | 01 авг 2022 г. |
| Tozzo Stephanie | A | 200000 | 200000 | 11 июл 2022 г. |
| Sarret Joseph J. | A | 650000 | 650000 | 29 дек 2021 г. |
| Biunno Jeffrey Francis | A | 75000 | 75000 | 29 дек 2021 г. |
| Barzilai Nir Yacov | A | 13889 | 13889 | 01 ноя 2021 г. |
| Barzilai Nir Yacov | A | 5075405 | 13889 | 01 ноя 2021 г. |
| GREENWOOD DAVID | A | 35000 | 20000 | 01 ноя 2021 г. |
| GREENWOOD DAVID | A | 40000 | 20000 | 01 ноя 2021 г. |
| Petkevich Misha | A | 407609 | 167000 | 28 окт 2021 г. |
Новостная лента
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
GlobeNewsWire
26 окт 2022 г. в 09:00
Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET
Cohbar Inc. (CWBR) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zacks Investment Research
21 окт 2022 г. в 13:33
Cohbar Inc. (CWBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
7 Nasdaq Stocks to Sell Before They Die
InvestorPlace
26 сент 2022 г. в 18:21
As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500.
CohBar (CWBR) Stock: 1-For-30 Reverse Split Goes Into Effect
Pulse2
23 сент 2022 г. в 08:35
A 1-for-30 reverse split of CohBar (CWBR) stock has gone into effect today. These are the details.
CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 09:00
MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that its Chief Executive Officer, Dr. Joseph Sarret, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held September 12 - 14, 2022.